2023 Predictions—the Good, the Bad, and the Ugly
What to expect in genetic engineering, neuroscience, psychedelics, longevity research, digital health, food, human performance, wellbeing, and of course, ChatGPT.
AI Versus Antibiotic Resistance
AI can help overcome both scientific and financial hurdles to tackle this serious threat to global health.
Sarcopenia: What a Waste
Sarcopenia, a muscle wasting disease, could shorten your life and is alarmingly prevalent. Why are so many people unaware it exists?
Is Low-Dose Lithium a Better Solution for Major Depression?
Some studies show it’s better than SSRIs—but there’s no incentive to invest in clinical trials.
Repurpose This Drug
How drugs that hit targets for depression and kidney disease could help people suffering physical pain.
Alex Zhavoronkov: Live Long and Prosper
The maniacally focused founder of Insilico Medicine is going all in on AI to discover new medicines and extend lifespan.
Does the Peer Review Process Need Blockchain?
A new generation of scientists raised on Reddit and Instagram are exploring crowdsourced models of scientific peer review.
What if We Didn’t Have to Test New Drugs on Animals?
As organ-on-a-chip technology comes of age, the bipartisan FDA Modernization Act 2.0 would remove the requirement that new drugs must undergo animal testing before human clinical trials.
Reproducibility in Clinical Trials is Like Trying to Catch a Rabbit by the Tail
Scientists are not routinely sloppy, clinicians don’t usually cheat, and clinical research is generally well designed. So why is it so hard to reproduce results?